Prolonged response to pembrolizumab in BRAFV600E - microsatellite stable metastatic colorectal cancer following an increase in tumor mutational burden
Favorite
Share
More Options
7

Open in WPS to view all 7 pages
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
